EPIVIR 150 mg/1
lamivudine · TABLET, FILM COATED · ViiV Healthcare Company
No Recall History
Plain English
EPIVIR is a tablet, film coated containing lamivudine at 150 mg/1, taken oral. Manufactured by ViiV Healthcare Company.
Key Facts
- Brand Name
- EPIVIR
- Generic Name
- lamivudine
- NDC Code (Product)
49702-203- Manufacturer
- ViiV Healthcare Company
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA020564
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 10/04/2010
Recall History
No Recall HistoryFrequently Asked Questions
What is EPIVIR used for?
EPIVIR contains lamivudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is EPIVIR a controlled substance?
EPIVIR is not classified as a controlled substance by the DEA.
What is the generic name for EPIVIR?
The generic name for EPIVIR is lamivudine. There are 12 other brand versions of lamivudine.
What is the NDC code for EPIVIR 150 mg/1?
The NDC (National Drug Code) for EPIVIR 150 mg/1 is 49702-203, listed by ViiV Healthcare Company.
Other Lamivudine Brands
See all →- LAMIVUDINE AND ZIDOVUDINE150 mg/172865-144
- lamivudine100 mg/131722-001
- Lamivudine300 mg/133342-002
- COMBIVIR150 mg/149702-202
- LAMIVUDINE150 mg/160505-3251
- LAMIVUDINE and ZIDOVUDINE150 mg/131722-506
- Lamivudine and Zidovudine150 mg/131722-739
- Lamivudine100 mg/131722-752
- Lamivudine150 mg/150742-623
- LAMIVUDINE300 mg/160505-3252
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)